Viking Therapeutics
VKTX
#2411
Rank
A$9.48 B
Marketcap
$85.15
Share price
-9.14%
Change (1 day)
447.20%
Change (1 year)

Earnings for Viking Therapeutics (VKTX)

Earnings in 2024 (TTM): -A$0.15 Billion

According to Viking Therapeutics 's latest financial reports the company's current earnings are N/A. In 2023 the company made an earning of -A$0.14 Billion a decrease over its 2022 earnings that were of -A$0.11 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Viking Therapeutics from 2014 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -A$0.15 Billion10.95%
2023 -A$0.14 Billion24.73%
2022 -A$0.11 Billion25.24%
2021 -A$85.05 Million39.23%
2020 -A$61.09 Million53.21%
2019 -A$39.87 Million16.84%
2018 -A$34.13 Million7.22%
2017 -A$31.83 Million39.68%
2016 -A$22.79 Million-37.05%
2015 -A$36.2 Million6.94%
2014 -A$33.85 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-A$0.81 Billion 424.51%๐Ÿ‡บ๐Ÿ‡ธ USA
A$5.82 M-103.80%๐Ÿ‡บ๐Ÿ‡ธ USA
A$33.18 M-121.64%๐Ÿ‡บ๐Ÿ‡ธ USA